Cystic Hyperplasia

Cystic endometrial hyperplasia (CEH) is a condition in which the lining of the uterus, known as the endometrium, undergoes abnormal thickening and develops fluid-filled cysts. This condition occurs almost exclusively in intact (unspayed) female dogs and is driven by the cumulative effects of progesterone during repeated estrous cycles. Over time, the endometrial tissue becomes increasingly disorganized and prone to secondary complications, most notably the development of pyometra, a life-threatening uterine infection.

The condition is part of a well-recognized clinical spectrum known as the cystic endometrial hyperplasia-pyometra complex. In this progression, the initial hormonal changes cause the uterine lining to proliferate abnormally, creating an environment that is highly susceptible to bacterial colonization. The cystic changes reduce the uterus's natural defense mechanisms and impair its ability to clear bacteria, setting the stage for infection.

CEH is considered one of the most common reproductive disorders in dogs. While it can occur in females of any age after their first heat cycle, the incidence increases significantly in middle-aged and older intact females. Dogs that have never been bred are at particularly elevated risk, as are those that have been treated with exogenous hormones such as progesterone-based drugs or estrogen compounds used for mismating injections.

Understanding CEH is critical for dog owners who maintain intact females, whether for breeding purposes or personal preference. Early recognition of the condition allows for timely intervention that can preserve fertility in breeding animals or prevent the serious and potentially fatal consequences of pyometra in non-breeding dogs.

The primary driver of cystic endometrial hyperplasia is prolonged or repeated exposure of the uterine lining to progesterone. During each estrous cycle, the ovaries produce progesterone following ovulation, which stimulates the endometrium to thicken in preparation for potential pregnancy. In a normal cycle where pregnancy does not occur, the uterine lining eventually returns to its baseline state. However, with each successive cycle, the cumulative effect of progesterone on the endometrium becomes more pronounced, leading to progressive structural changes.

Age is one of the most significant risk factors for developing CEH. Dogs over the age of six years that have undergone multiple estrous cycles without pregnancy are at substantially higher risk. The endometrium of these dogs has been subjected to years of cyclical hormonal stimulation, resulting in a thickened and increasingly abnormal uterine lining. Statistical studies indicate that the majority of CEH cases are diagnosed in dogs between six and ten years of age.

Exogenous hormone administration is another important contributing factor. Progesterone-based drugs, sometimes used to suppress estrus or manage certain behavioral conditions, can accelerate the development of CEH. Similarly, estrogen compounds historically used as mismating injections have been shown to increase progesterone receptor sensitivity in the endometrium, compounding the effects of naturally occurring progesterone and hastening the onset of cystic changes.

Breed predisposition plays a role in CEH susceptibility. While any intact female dog can develop the condition, certain breeds appear to be affected more frequently and at younger ages. Bernese Mountain Dogs, Rottweilers, Golden Retrievers, Cavalier King Charles Spaniels, and English Springer Spaniels have all been identified as breeds with higher incidence rates. This suggests a genetic component to the condition, though the specific hereditary mechanisms remain under investigation.

Other factors that may contribute to CEH development include irregular estrous cycles, ovarian cysts that produce abnormal hormone levels, and prolonged diestrus periods. Dogs with ovarian pathology that results in sustained progesterone production are particularly vulnerable to accelerated endometrial changes.

In its early stages, cystic endometrial hyperplasia may produce few or no outwardly visible symptoms. The condition often develops silently over the course of multiple estrous cycles, with the endometrial changes occurring internally without causing obvious discomfort or behavioral changes in the dog. This subclinical nature of early CEH makes it challenging to detect without diagnostic imaging or direct visualization of the uterus.

As the condition progresses, some dogs may exhibit a vaginal discharge that occurs during or shortly after the diestrus phase of the estrous cycle. This discharge may be clear, mucoid, or slightly blood-tinged, and it reflects the increased fluid accumulation within the cystic endometrial glands. Owners may notice staining on bedding or excessive licking of the vulvar area. In some cases, the discharge may be intermittent and easily overlooked.

Fertility problems are often the first clinical indicator that alerts breeders to the presence of CEH. Affected dogs may experience difficulty conceiving, early embryonic resorption, or reduced litter sizes. The abnormal endometrial environment disrupts normal implantation and placental development, making successful pregnancy increasingly unlikely as the condition advances. Breeders who track reproductive performance closely may notice a progressive decline in breeding success over successive cycles.

When CEH progresses to the pyometra stage, symptoms become much more apparent and urgent. Dogs with open-cervix pyometra will have a noticeable purulent or blood-tinged vaginal discharge. Those with closed-cervix pyometra, in which the infected fluid is trapped within the uterus, may show abdominal distension, lethargy, loss of appetite, increased thirst and urination, vomiting, and fever. Closed-cervix pyometra is particularly dangerous because the accumulating pus can lead to uterine rupture and fatal peritonitis.

Systemic signs of illness in advanced cases may include dehydration, depression, weakness, and collapse. These signs indicate that bacterial toxins have entered the bloodstream, creating a septic condition that requires emergency veterinary intervention. Any intact female dog showing signs of systemic illness, particularly within weeks of her last heat cycle, should be evaluated immediately for possible pyometra.

Diagnosis of cystic endometrial hyperplasia typically begins with a thorough history and physical examination. Veterinarians will inquire about the dog's reproductive history, including the timing of her last estrous cycle, any previous pregnancies, and whether exogenous hormones have been administered. Physical examination may reveal vaginal discharge, abdominal tenderness, or palpable uterine enlargement, though these findings are not always present in early-stage disease.

Abdominal ultrasonography is the most valuable non-invasive diagnostic tool for identifying CEH. Ultrasound can reveal characteristic changes in the uterine wall, including endometrial thickening, the presence of fluid-filled cysts within the endometrial lining, and intraluminal fluid accumulation. The degree of uterine enlargement and the nature of the fluid contents can help differentiate uncomplicated CEH from pyometra. Ultrasonography also allows assessment of the ovaries for concurrent pathology such as ovarian cysts or tumors.

Radiography may be used as a complementary imaging modality, particularly when pyometra is suspected. While radiographs cannot provide the detailed endometrial visualization that ultrasound offers, they can demonstrate significant uterine enlargement. A markedly enlarged, fluid-filled uterus is often visible on abdominal radiographs as a tubular soft tissue density in the caudal abdomen. Radiography is also useful for ruling out other causes of abdominal distension.

Blood work including a complete blood count and serum biochemistry panel is important for assessing the overall health of the dog and detecting secondary complications. Dogs with pyometra often exhibit a marked leukocytosis with a left shift, indicating an active bacterial infection. Elevations in blood urea nitrogen and creatinine may suggest renal compromise secondary to bacterial toxemia. Progesterone levels can be measured to confirm the hormonal status and phase of the estrous cycle.

Definitive diagnosis of CEH is made through histopathological examination of the uterine tissue, typically obtained following ovariohysterectomy. Microscopic evaluation reveals the characteristic cystic dilation of endometrial glands, stromal edema, and varying degrees of inflammatory infiltration. Histopathology also allows classification of the disease stage and assessment for concurrent neoplastic changes, providing important prognostic information.

The cystic endometrial hyperplasia-pyometra complex is traditionally classified into four progressive stages based on the severity of endometrial changes and the presence of secondary infection. Understanding these stages is important for both prognosis and treatment planning, as the approach to management may differ significantly depending on the degree of disease progression.

Stage I is characterized by uncomplicated cystic endometrial hyperplasia without inflammation or infection. The endometrial glands are dilated and filled with clear fluid, and the surrounding stroma may show edema. At this stage, the uterine environment is abnormal but has not yet been colonized by bacteria. Dogs in Stage I may show no clinical signs, and the condition is often discovered incidentally during ultrasonographic examination or at the time of elective spay surgery.

Stage II represents CEH with diffuse endometrial infiltration by inflammatory cells, primarily plasma cells. This stage reflects early immune system activation in response to the abnormal endometrial environment, even in the absence of overt bacterial infection. The endometrial surface may show areas of erosion or ulceration, and small amounts of sterile inflammatory fluid may accumulate within the uterine lumen. Fertility is typically compromised at this stage.

Stage III is defined by the presence of frank pyometra, with bacterial infection superimposed on the existing cystic endometrial changes. The uterine lumen contains purulent material, and the endometrium shows marked inflammation with neutrophilic infiltration. The bacteria most commonly isolated from pyometra cases is Escherichia coli, which ascends from the vaginal flora through the cervix during estrus. Stage III is further subdivided based on whether the cervix is open, allowing drainage of infected material, or closed, trapping the infection within the uterus.

Stage IV represents chronic endometritis with severe, irreversible changes to the uterine wall. The endometrium may show extensive fibrosis, glandular atrophy in some areas alongside continued cystic change in others, and deep myometrial involvement. The uterine wall may become dangerously thin in areas, increasing the risk of rupture. Dogs at this stage typically have a poor prognosis for fertility and require definitive surgical treatment.

Progression through these stages is not always linear or predictable. Some dogs may remain at Stage I for extended periods, while others may progress rapidly to Stages III or IV within a single estrous cycle. Factors influencing the rate of progression include the dog's immune status, the degree of hormonal stimulation, and the bacterial load present in the reproductive tract.

Ovariohysterectomy, the surgical removal of the ovaries and uterus, is considered the gold standard treatment for cystic endometrial hyperplasia and is the only option that provides a definitive cure. This procedure eliminates the source of hormonal stimulation and removes the diseased tissue entirely, preventing recurrence and eliminating the risk of progression to pyometra. For dogs that are not intended for breeding, ovariohysterectomy is strongly recommended as soon as the diagnosis is confirmed.

In cases where CEH has already progressed to pyometra, ovariohysterectomy becomes an emergency procedure. Preoperative stabilization with intravenous fluid therapy, broad-spectrum antibiotics, and supportive care is essential before surgery, particularly in dogs showing signs of sepsis or dehydration. The surgical procedure in pyometra cases carries higher risks than elective spay surgery due to the fragile, enlarged uterine tissue and the compromised condition of the patient, but it remains the most effective and safest treatment approach.

Medical management may be considered for valuable breeding dogs in the early stages of CEH where the owner wishes to preserve fertility. Prostaglandin F2-alpha is the most commonly used medical treatment, as it promotes uterine contraction and cervical relaxation, facilitating drainage of uterine contents. This treatment is typically administered under close veterinary supervision due to its side effects, which can include vomiting, diarrhea, abdominal discomfort, restlessness, and transient cardiovascular changes.

Aglepristone, a progesterone receptor antagonist, has shown promise in the medical management of CEH and pyometra in some countries. By blocking the effects of progesterone on the endometrium, aglepristone can reduce endometrial stimulation and promote cervical opening. It is often used in combination with prostaglandins and antibiotics for a multimodal approach to medical management. However, availability of this drug varies by region.

It is important to note that medical management is considered a temporizing measure rather than a cure. Dogs treated medically for CEH have a high recurrence rate, with studies reporting recurrence in up to 77 percent of cases within subsequent estrous cycles. Therefore, medical management is typically recommended only for dogs that will be bred during the immediately following cycle, with ovariohysterectomy planned after their breeding career is complete.

Ovariohysterectomy for cystic endometrial hyperplasia or pyometra requires careful surgical planning and execution. Unlike routine spay procedures performed on healthy dogs, surgery on a uterus affected by CEH presents unique challenges. The uterine walls may be thickened and friable, the blood supply may be engorged, and in pyometra cases the uterine horns may be massively distended with purulent fluid, requiring careful handling to prevent rupture during manipulation.

Preoperative assessment is critical, particularly in dogs with concurrent pyometra. A complete blood count, serum biochemistry, urinalysis, and coagulation panel should be performed to evaluate organ function and identify any coagulopathies that could complicate surgery. Abdominal imaging helps the surgeon anticipate the size and condition of the uterus, allowing for appropriate surgical planning including incision length and the potential need for additional assistance.

Anesthetic management in these patients requires careful consideration of their compromised physiological status. Dogs with sepsis may have hemodynamic instability, and standard anesthetic protocols may need to be modified. Continuous monitoring of blood pressure, heart rate, oxygen saturation, and body temperature throughout the procedure is essential. Fluid therapy should be maintained intraoperatively and continued postoperatively to support cardiovascular function and renal perfusion.

Postoperative care typically involves continued intravenous fluid therapy, antibiotic administration based on culture and sensitivity results from the uterine contents, and appropriate analgesia. Most dogs begin to show significant clinical improvement within 24 to 48 hours of surgery as the source of infection is removed and antibiotic therapy takes effect. Monitoring of renal parameters in the postoperative period is important, as some dogs develop a transient polyuria and polydipsia as the kidneys recover from the effects of bacterial endotoxins.

Recovery from uncomplicated ovariohysterectomy for CEH without pyometra is generally straightforward and similar to recovery from a routine spay procedure. The dog should be restricted from strenuous activity for 10 to 14 days to allow proper incision healing. Suture or staple removal, if non-absorbable materials were used, is typically performed at the two-week postoperative recheck. Most dogs return to their normal activity level within three to four weeks of surgery.

The prognosis for dogs with cystic endometrial hyperplasia depends largely on the stage of disease at the time of diagnosis and the treatment approach selected. Dogs that undergo ovariohysterectomy during the early stages of CEH, before the development of pyometra or systemic illness, have an excellent prognosis with survival rates approaching 100 percent. These dogs can be expected to make a full recovery and live normal, healthy lives following surgery.

For dogs with open-cervix pyometra that receive prompt surgical treatment, the prognosis is generally good, with reported survival rates of 90 to 95 percent. The ability of the uterus to drain through the open cervix partially mitigates the risk of uterine rupture and reduces the systemic bacterial load, allowing most of these patients to respond well to surgical intervention combined with appropriate antimicrobial therapy.

Closed-cervix pyometra carries a more guarded prognosis, particularly when diagnosis or treatment is delayed. The trapped infection can lead to rapid systemic deterioration, and the distended uterus is at risk of rupture, which can cause fatal peritonitis. Even with emergency surgery, dogs with advanced closed-cervix pyometra and sepsis may have survival rates as low as 70 to 80 percent. Pre-existing organ damage, particularly to the kidneys, may result in ongoing health concerns even after successful surgery.

For dogs managed medically to preserve breeding potential, the prognosis for fertility is variable. Some dogs may conceive successfully during the cycle immediately following medical treatment, but the likelihood of conception decreases with advancing stages of CEH. The recurrence rate following medical management is high, and each subsequent episode may be more severe than the last, further compromising both fertility and overall health.

Long-term complications following successful treatment of CEH are uncommon in dogs that undergo ovariohysterectomy. However, dogs that experienced significant sepsis or renal compromise prior to surgery should be monitored periodically for signs of chronic kidney disease. Additionally, spayed dogs may be at slightly increased risk for certain conditions such as obesity and urinary incontinence, which should be managed proactively through appropriate diet, exercise, and veterinary care.

Dogs diagnosed with early-stage cystic endometrial hyperplasia that are being managed medically require close monitoring and diligent owner involvement. Regular veterinary visits, typically every one to three months, are necessary to assess disease progression through ultrasonographic examination of the uterus. Owners should maintain a detailed record of the dog's estrous cycles, including timing, duration, and any associated discharge, as changes in these patterns may indicate disease progression.

Recognizing warning signs of pyometra development is essential for owners of dogs with known CEH. Any change in the character or volume of vaginal discharge, lethargy, decreased appetite, increased water consumption, or abdominal enlargement should prompt immediate veterinary evaluation. Owners should be educated about the difference between open and closed pyometra presentations, understanding that the absence of vaginal discharge does not rule out a serious uterine infection.

Nutritional support plays a role in maintaining the overall health and immune function of dogs with CEH. A balanced, high-quality diet that supports immune system function can help the body manage the chronic endometrial changes more effectively. Maintaining an appropriate body weight is also important, as obesity can exacerbate hormonal imbalances and increase the anesthetic risk should emergency surgery become necessary.

Environmental management includes keeping the dog's living area clean and minimizing exposure to potential sources of bacterial contamination, particularly during and immediately after estrus when the cervix is relaxed and the uterus is most vulnerable to ascending infection. Good hygiene practices, including regular cleaning of bedding and monitoring of the perineal area, can help reduce the bacterial load in the dog's environment.

Emotional and psychological well-being should not be overlooked in dogs with chronic reproductive conditions. Dogs that experience repeated veterinary visits, medical treatments, and the physical discomfort associated with CEH may benefit from stress reduction strategies, environmental enrichment, and consistent, reassuring interactions with their owners. Maintaining normal routines and activities as much as possible helps support the dog's overall quality of life while managing the condition.

Understanding when cystic endometrial hyperplasia requires emergency intervention can be the difference between life and death for an affected dog. The most critical situation arises when CEH progresses to closed-cervix pyometra, where the infected uterine contents are trapped with no route for drainage. This condition can deteriorate rapidly, with dogs progressing from apparently normal behavior to critical illness within 24 to 48 hours. Any intact female dog showing sudden onset of lethargy, anorexia, vomiting, or abdominal distension, particularly within two to eight weeks of her last heat cycle, should be treated as a potential emergency.

Excessive or foul-smelling vaginal discharge is another reason to seek urgent veterinary attention. While some vaginal discharge can be normal during certain phases of the estrous cycle, discharge that is purulent, dark-colored, malodorous, or unusually copious suggests active uterine infection. Even in open-cervix pyometra, where the drainage provides some degree of decompression, the infection can still cause serious systemic illness if not treated promptly.

Signs of systemic infection or sepsis represent the most urgent scenario and demand immediate emergency care. These signs include a high fever or subnormal body temperature, rapid heart rate, rapid or labored breathing, pale or muddy mucous membranes, weakness or collapse, and altered mental status. Sepsis from pyometra can lead to disseminated intravascular coagulation, acute kidney injury, and multiple organ failure, all of which carry high mortality rates without aggressive intervention.

Sudden abdominal pain or a rapidly distending abdomen in a dog with known CEH or suspected pyometra may indicate uterine rupture, a catastrophic complication that releases infected material into the peritoneal cavity. This results in septic peritonitis, which is invariably fatal without emergency surgical intervention. Dogs showing signs of acute abdominal crisis should be transported to an emergency veterinary facility immediately.

Owners of intact female dogs should establish a relationship with an emergency veterinary facility before a crisis occurs, ensuring they know the location, contact information, and hours of operation of the nearest emergency clinic. Having this information readily available can save precious time in an emergency situation when every minute counts toward a successful outcome.